1. In Vitro and in Vivo Anti-platelet Effects of Enzymatic Hydrolysates of Collagen and Collagen-related Peptides
- Author
-
Tamotsu Shigehisa, Shin-ichiro Katsuda, Takashi Ohmori, Isao Nonaka, Tatsuyoshi Nakagami, and Susumu Maruyama
- Subjects
chemistry.chemical_classification ,animal structures ,integumentary system ,Organic Chemistry ,Peptide ,Biological activity ,General Medicine ,Applied Microbiology and Biotechnology ,Biochemistry ,In vitro ,Analytical Chemistry ,Thrombin ,chemistry ,In vivo ,embryonic structures ,Collagenase ,medicine ,Platelet aggregation inhibitor ,Platelet ,Molecular Biology ,Biotechnology ,medicine.drug - Abstract
Collagen-related peptides, Gly-Pro-Arg and its analogues, were examined for their inhibitory effects on platelet aggregation induced by the addition of ADP. Human platelet aggregation was suppressed by more than 50% with each of Gly-Pro-Arg and such Gly-Pro-Arg-containing peptides as Gly-Pro-Arg-Gly, Gly-Pro-Arg-Gly-Pro, Gly-Pro-Arg-Pro-Pro, and Gly-Pro-Arg-Pro-Pro-Pro at a concentration of 0.3 mM. The inhibitory effects of these peptides were about 10 times higher in human PRP than in rat PRP. Other Gly-Pro-Arg analogues such as Sar-Pro-Arg, Gly-Pro-Lys, Gly-Ala-Arg, and Ala-Gly-Pro-Arg had no inhibitory effect at a concentration from 0.1 to 0.8 mM even in human PRP. Intravenous and oral administrations of Gly-Pro-Arg and enzymatic hydrolysates of collagen suppressed the decrease in platelet count for endotoxin-induced DIC in rats. Collagen itself has been regarded as a potent inducer of platelet aggregation, but these findings suggest that collagen-related peptides and enzymatic hydrolysates of collagen prevent platelet aggregation.
- Published
- 2017